SECOND AUTOLOGOUS STEM CELL TRANSPLANTATION FOR RELAPSED LYMPHOMA AFTER A PRIOR AUTOLOGOUS TRANSPLANT

We determined treatment-related mortality (TRM), progression free survival (PFS), and overall survival (OS) after a second autologous HCT (HCT2) for patients with lymphoma relapse after a prior HCT (HCT1). Outcomes for patients with either Hodgkin lymphoma (HL, n=21) or non-Hodgkin lymphoma (NHL, n=...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Smith, Sonali M., van Besien, Koen, Carreras, Jeanette, Bashey, Asad, Cairo, Mitchell S., Freytes, Cesar O., Gale, Robert Peter, Hale, Gregory A., Hayes-Lattin, Brandon, Holmberg, Leona A., Keating, Armand, Maziarz, Richard T., McCarthy, Philip L., Navarro, Willis H., Pavlovsky, Santiago, Schouten, Harry C., Seftel, Matthew, Wiernik, Peter H., Vose, Julie M., Lazarus, Hillard M., Hari, Parameswaran
Médium: Artigo
Jazyk:Inglês
Vydáno: 2008
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3353768/
https://ncbi.nlm.nih.gov/pubmed/18640574
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2008.05.021
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky